These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4037771)

  • 1. Difference in blister fluid penetration after single and multiple doses of ceftriaxone.
    LeBel M; Grégoire S; Caron M; Bergeron MG
    Antimicrob Agents Chemother; 1985 Jul; 28(1):123-7. PubMed ID: 4037771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid.
    Kalager T; Digranes A; Bergan T; Solberg CO
    J Antimicrob Chemother; 1984 May; 13(5):479-85. PubMed ID: 6330020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime.
    Wise R; Andrews JM
    Eur J Clin Microbiol; 1983 Oct; 2(5):505-8. PubMed ID: 6315427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.
    Scully BE; Fu KP; Neu HC
    Am J Med; 1984 Oct; 77(4C):112-6. PubMed ID: 6093511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C
    Chemotherapy; 1985; 31(2):85-94. PubMed ID: 3987394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers.
    Korting HC; Schäfer-Korting M; Maass L; Klesel N; Mutschler E
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1822-5. PubMed ID: 3435129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoconazole concentrations in human skin blister fluid and plasma.
    Schäfer-Korting M; Korting HC; Dorn M; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):371-4. PubMed ID: 6088407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the extravascular distribution of cefotiam (SCE 963) by the skin blister technic].
    Bryskier A; Elbaz P; Fourtillan JB; Ortonne JP
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):506-8. PubMed ID: 6087248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.
    Pollock AA; Tee PE; Patel IH; Spicehandler J; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1982 Nov; 22(5):816-23. PubMed ID: 6295268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefodizime penetration into skin suction blister fluid following a single intravenous dose.
    Schäfer-Korting M; Korting HC; Maass L; Klesel N; Grigoleit HG; Mutschler E
    Eur J Clin Pharmacol; 1986; 30(3):295-8. PubMed ID: 3732363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transfer of cefmenoxime to burn blister fluids].
    Nishizaki A; Aoyama H; Koh T; Izawa Y
    Jpn J Antibiot; 1984 Mar; 37(3):295-302. PubMed ID: 6330396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea.
    Korting HC; Schäfer-Korting M; Haag R; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):218-20. PubMed ID: 6325353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and skin blister fluid levels of cefotiam and cefmenoxime after single intramuscular application of 1 g in gonorrhea.
    Korting HC
    Chemotherapy; 1984; 30(5):277-82. PubMed ID: 6092005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of ceftriaxone in man.
    Patel IH; Kaplan SA
    Am J Med; 1984 Oct; 77(4C):17-25. PubMed ID: 6093513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of tinidazole into skin blister fluid following its oral administration.
    Klimowicz A; Nowak A; Bielecka-Grzela S
    Eur J Clin Pharmacol; 1992; 43(5):523-6. PubMed ID: 1483489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of ceftriaxone in patients with neoplastic disease.
    Salvador P; Smith RG; Weinfeld RE; Ellis DH; Bodey GP
    Antimicrob Agents Chemother; 1983 Apr; 23(4):583-8. PubMed ID: 6305263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
    Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Wilber RB; Pittman KA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1204-9. PubMed ID: 2393282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents.
    Patel IH; Weinfeld RE; Konikoff J; Parsonnet M
    Antimicrob Agents Chemother; 1982 Jun; 21(6):957-62. PubMed ID: 6287931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.
    Nahata MC; Durrell DE; Barson WJ
    Chemotherapy; 1986; 32(2):89-94. PubMed ID: 3698727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.